Skip to main content
logo
Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.1021
-0.0015 (-1.45%)
Oct 19, 2026, 11:55 AM EST

Hepion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1013142387
Market Cap Growth
915.29%-78.69%-76.72%-38.61%-73.66%23.90%
Enterprise Value
1006-3-34-10
Last Close Price
0.100.0623.50162.00300.301140.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
7.960.26-1.761.930.460.93
P/TBV Ratio
-0.72-2.520.511.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-1.560.030.000.00
Net Debt / Equity Ratio
-1.27-0.66-1.34-2.00-1.03-0.98
Net Debt / EBITDA Ratio
-0.48-0.130.321.173.00
Net Debt / FCF Ratio
1.020.54-0.140.361.462.90
Quick Ratio
3.316.110.132.806.4911.13
Current Ratio
3.9110.250.513.317.1611.88
Return on Equity (ROE)
-125.64%-2058.63%-487.03%-171.26%-59.08%-49.02%
Return on Assets (ROA)
-61.16%-100.37%-122.71%-72.21%-33.29%-24.97%
Return on Capital Employed (ROCE)
-219.40%-135.70%1264.40%-353.50%-83.30%-31.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-31.33%-1187.27%-403.30%-348.13%-184.35%-37.66%
FCF Yield
-15.67%-469.22%-556.88%-291.04%-152.80%-36.08%
Buyback Yield / Dilution
-251.78%-7556.50%-54.75%-4.18%-8.45%-